Literature DB >> 16681764

Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer.

H Nomura1, D Aoki, N Suzuki, N Susumu, A Suzuki, Y Tamada, F Kataoka, A Higashiguchi, S Ezawa, S Nozawa.   

Abstract

The purposes of this study were to compare the relationships between para-aortic lymph node metastasis and various clinicopathologic factors to evaluate whether para-aortic lymph node dissection is necessary when treating endometrial cancer. A retrospective study was performed on 841 patients with endometrial cancer, who underwent the initial surgery at the Keio University Hospital. Clinicopathologic factors related to para-aortic lymph node metastasis significant on a univariate analysis were analyzed in a multivariate fashion using a logistic model. According to the multivariate analysis, the clinicopathologic factor most strongly related to the existence of para-aortic lymph node metastasis was positive pelvic lymph node metastasis (P < 0.01). Among the 155 patients who underwent pelvic and para-aortic lymph node dissection, the difference of 5-year overall survival by the presence of retroperitoneal lymph node metastasis was examined by Kaplan-Meier method. The prognosis was poor even if para-aortic lymph node dissection was performed in cases of positive para-aortic lymph node metastasis. In conclusion, when deciding whether to perform para-aortic lymph node dissection in patients with endometrial cancer, it is necessary to consider the pelvic lymph nodal status. If there is no pelvic lymph node metastasis, it could not be necessary to perform para-aortic lymph node dissection.

Entities:  

Mesh:

Year:  2006        PMID: 16681764     DOI: 10.1111/j.1525-1438.2006.00529.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  14 in total

1.  Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.

Authors:  Ismail Alay; Taner Turan; Isin Ureyen; Alper Karalok; Tolga Tasci; Ahmet Ozfuttu; M Faruk Kose; Gokhan Tulunay
Journal:  Pathol Oncol Res       Date:  2015-01-07       Impact factor: 3.201

2.  The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer.

Authors:  Praveen S Rathod; P N Shakuntala; V R Pallavi; Rajashekar Kundaragi; B Shankaranand; C R Vijay; K Uma Devi; Uttam D Bafna
Journal:  Indian J Surg Oncol       Date:  2014-03-28

3.  Risk factors for paraaortic lymph node metastasis in endometrial cancer.

Authors:  Mustafa Erkan Sari; İbrahim Yalcin; Hanifi Sahin; Mehmet Mutlu Meydanli; Tayfun Gungor
Journal:  Int J Clin Oncol       Date:  2017-05-18       Impact factor: 3.402

4.  Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.

Authors:  Andrea Mariani; Sean C Dowdy; William A Cliby; Bobbie S Gostout; Monica B Jones; Timothy O Wilson; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2008-03-04       Impact factor: 5.482

5.  Controversies in the management of endometrial carcinoma: an update.

Authors:  Mohamed K Mehasseb; John A Latimer
Journal:  Obstet Gynecol Int       Date:  2012-02-16

6.  Establishment of the retroperitoneal lymph node metastasis model of endometrial VX2 carcinoma in rabbits and observation of its metastatic features.

Authors:  Li-Qun Xu; Yong-Wen Huang; Rong-Zhen Luo; Yan-Na Zhang
Journal:  World J Surg Oncol       Date:  2015-03-14       Impact factor: 2.754

7.  VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis.

Authors:  Yong-Wen Huang; Li-Qun Xu; Rong-Zhen Luo; Xin Huang; Teng Hou; Yan-Na Zhang
Journal:  Reprod Biol Endocrinol       Date:  2013-05-21       Impact factor: 5.211

8.  Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection.

Authors:  Alessandro Buda; Andrea Lissoni; Rodolfo Milani
Journal:  J Gynecol Oncol       Date:  2015-12-07       Impact factor: 4.401

9.  Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.

Authors:  Vakkas Korkmaz; Mehmet Mutlu Meydanli; Ibrahim Yalçın; Mustafa Erkan Sarı; Hanifi Sahin; Eda Kocaman; Ali Haberal; Polat Dursun; Tayfun Güngör; Ali Ayhan
Journal:  J Gynecol Oncol       Date:  2017-11       Impact factor: 4.401

10.  Lymph node dissection in atypical endometrial hyperplasia.

Authors:  Salih Taşkın; Özgür Kan; Ömer Dai; Elif A Taşkın; Kazibe Koyuncu; Ayşegül Alkılıç; Mete Güngör; Fırat Ortaç
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.